4 found
Order:
  1.  27
    Challenges and Opportunities for Biomarker Validation.Spencer Phillips Hey, Elvira D'Andrea, Emily H. Jung, Frazer Tessema, Jing Luo, Bishal Gyawali & Aaron S. Kesselheim - 2019 - Journal of Law, Medicine and Ethics 47 (3):357-361.
    Biomarkers can be powerful tools to guide diagnosis, treatment, and research. However, prudent use of biomarkers requires formal validation efforts. Although the data needed for biomarker validation has traditionally been hard to access, new research initiatives can ease this process.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  2.  6
    Economics of Cancer Medicines: For Whose Benefit?Bishal Gyawali & Richard Sullivan - 2017 - The New Bioethics 23 (1):95-104.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  3. Cervical cancer screening in Nepal: ethical considerations.Bishal Gyawali, June Keeling, Edwin van Teijlingen, Liladhar Dhakal & Arja Aro - forthcoming - Medicolegal and Bioethics:1.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  4.  8
    Lung Cancer Survival Gains: Contributions of Academia and Industry.Bishal Gyawali, Gauthier Bouche, Pan Pantziarka, Aaron S. Kesselheim & Ameet Sarpatwari - 2019 - Journal of Law, Medicine and Ethics 47 (3):465-467.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark